Systemic Administration of HVJ Viral Coat–Liposome Complex Containing Human Insulin Vector Decreases Glucose Level in Diabetic Mouse: A Model of Gene Therapy
- 5 July 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 273 (2) , 666-674
- https://doi.org/10.1006/bbrc.2000.2936
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Adenoviral Gene Therapy Leads to Rapid Induction of Multiple Chemokines and Acute Neutrophil-Dependent Hepatic Injury in VivoHuman Gene Therapy, 1999
- Gene therapy: into the future of surgeryThe Lancet, 1999
- Adenovirus-mediated Gene Therapy of Liver DiseasesSeminars in Liver Disease, 1999
- Adenoviral delivery of low-density lipoprotein receptors to hyperlipidemic rabbits: Receptor expression modulates high-density lipoproteinsMetabolism, 1996
- Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus–mediated transfer of the VLDL receptor geneNature Genetics, 1996
- Adenovirus mediated expression of therapeutic plasma levels of human factor IX in miceNature Genetics, 1993
- Gene therapy for cardiovascular diseaseTrends in Biotechnology, 1993
- At Age 2, Gene Therapy Enters a Growth PhaseScience, 1992
- Transplantation of Genetically Modified Autologous Hepatocytes into Nonhuman Primates: Feasibility and Short-Term ToxicityHuman Gene Therapy, 1992
- Human gene therapy comes of ageNature, 1992